BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8121485)

  • 1. Towards a better aspirin.
    Vane J
    Nature; 1994 Jan; 367(6460):215-6. PubMed ID: 8121485
    [No Abstract]   [Full Text] [Related]  

  • 2. COX in a crystal ball: current status and future promise of prostaglandin research.
    FitzGerald GA; Loll P
    J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
    [No Abstract]   [Full Text] [Related]  

  • 3. Closing in on a stomach-sparing aspirin substitute.
    Service RF
    Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible inconsistencies in study on cyclooxygenase.
    Kay-Mugford T; Conlon P
    Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin resistance transient laboratory finding or important clinical entity?
    Lev EI
    J Am Coll Cardiol; 2009 Feb; 53(8):678-80. PubMed ID: 19232900
    [No Abstract]   [Full Text] [Related]  

  • 6. Picture story. COX complexes.
    Feng H
    Nat Struct Biol; 2000 Jun; 7(6):448. PubMed ID: 10881188
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin--now we can see it.
    Allen KN
    Nat Med; 1995 Sep; 1(9):882-3. PubMed ID: 7585209
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
    Bracher F; Krauss J; Laufer S
    Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin and inflammation.
    Nat Struct Biol; 1995 Aug; 2(8):605-6. PubMed ID: 7552717
    [No Abstract]   [Full Text] [Related]  

  • 10. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase.
    Loll PJ; Picot D; Garavito RM
    Nat Struct Biol; 1995 Aug; 2(8):637-43. PubMed ID: 7552725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 12. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
    Buccellati C; Sala A; Ballerio R; Bianchib M
    Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
    Wu KK
    Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.